YB1 Bio

港药溶瘤

YB1 Bio

Biotech/Healthcare

Gangyao Rongliu is an innovative drug R&D and manufacturing company focused on developing innovative drugs in the field of tumor-targeted therapy. It owns an oncolytic drug bacterial delivery/presentation platform based on synthetic biology, providing cancer immunotherapy solutions.

Latest round: Pre Series A (2021)

Source: ChinaBulls — chinabulls.com

Last updated 2021-08-01